Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria

Journal of Infectious Diseases

Volumn 181, Issue 3, 2000, Pages 1202-1205

  Dodoo, Daniel ^a,b   Theisen, Michael ^c   Kurtzhals, Joørgen A L ^a,b   Akanmori, Bartholomew D ^a   Koram, Kwadwo A ^a   Jepsen, Søren ^c   Nkrumah, Francis K ^a   Theander, Thor G ^b   Hviid, Lars ^b,d  

^a University of Ghana   (Ghana)

^b Mental Health Services CPH   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; IMMUNOGLOBULIN G; MALARIA VACCINE; PROTEIN ANTIBODY;

ADOLESCENT; AGE; ANTIBODY RESPONSE; ARTICLE; CHILD; FEMALE; GHANA; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADOLESCENT; ANIMALS; ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS;

EID: 0034078401     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315341     Document Type: Article

References (14)

1. 1. 1. Borre MB, Dziegiel M, Hogh B, et al. Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate lifecycle. Mol Biochem Parasitol 1991;49:119-32.
2. 2. Theisen M, Soe S, Oeuvray C, Thomas AW, et al. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun 1998;66:11-7.
3. 3. Khusmith S, Druilhe P. Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum. Infect Immun 1983;41:219-23.
4. 4. Lunel F, Druilhe P. Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro. Infect Immun 1989;57:2043-9.
5. 5. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 1990;172: 1633-41.
6. 6. Bouharoun-Tayoun H, Druilhe P. Plasmodium jaiciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 1992;60:1473-81.
7. 7. Hogh B, Petersen E, Dziegiel M, et al. Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia. Am J Trop Med Hyg 1992;46: 307-13.
8. 8. Dziegiel M, Rowe P, Bennett S, Allen SJ et al. Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect Immun 1993;61:103-8.
9. 9. Afari EA, Appawu M, Dunyo S, Baffoe-Wilmot A, Nkrumah FK. Malaria infection, morbidity and transmission in two ecological zones in southern Ghana. Afr J Health Sci 1995;2:312-6.
10. 10. Dodoo D, Theander TG, Kurtzhals JAL, et al. Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with clinical protection from malaria. Infect Immun 1999;67:2131-7.
11. 11. Theisen M, Vuust J, Gottschau A, Jepsen S, Hogh B. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin Diagn Lab Immunol 1995;2: 30-4.
12. 12. Dziegiel M, Borre MB, Jepsen S, Hogh B, Petersen E, Vuust J. Recombinant Plasmodium falciparum glutamate rich protein: purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1991;44: 306-13.
13. 13. Theisen M, Cox G, Hogh B, Jepsen S, Vuust J. Immunogenicity of the Plasmodium falciparum glutamate-rich protein expressed by vaccinia virus. Infect Immun 1994;62:3270-5.
14. 14. Petersen E, Hogh B, Dziegiel M, et al. The antibody response to well-defined malaria antigens after acute malaria in individuals living under continuous malaria transmission. Acta Trop 1992;51:135-42.